Notice of extraordinary general meeting in InDex Pharmaceuticals Holding AB (publ)
May 23, 2024 - The shareholders of InDex Pharmaceuticals Holding AB , reg.no. 559067-6820 (the "Company" or "InDex Pharmaceuticals"), are hereby summoned to an extraordinary general meeting on Monday June 10, 2024 at 08.30 a.m. CEST at Setterwalls Advokatbyrå's premises at Sturegatan 10 in Stockholm.NoticeShareholders wishing to participate in the meeting must: (i) be entered in the shareholders’ register, kept by Euroclear Sweden AB on the record day which is Thursday, May 30, 2024; and (ii) no later than Monday, June 3, 2024, have notified the Company of their participation and